Vascular Pharmaceuticals, Inc. — Form D/A

Vascular Pharmaceuticals, Inc. of CARY, NC, a company, filed a Form D amendment with the SEC on 2015-02-20. The offering totals $25.1M, of which $15.1M was reported sold. Industry: Biotechnology.

Offering

Filed: 2015-02-20
Form: D/A
Accession: 0001557160-15-000002
Industry: Biotechnology
Exemptions: 06b
Total offering: $25.1M
Amount sold: $15.1M
Remaining: $10.0M
Investors: 6
Date of first sale: 2012-09-10
Security types: equity
Revenue range: Decline to Disclose
SEC file number: 021-184519

Issuer

Name: Vascular Pharmaceuticals, Inc.
CIK: 0001557160
Entity type: Corporation
Jurisdiction: DELAWARE
Address: 903 WALCOTT WAY, CARY, NC, 27519
Phone: 919-345-7933

Officers, directors & promoters (10)

Name	Role	Location
Richard Kent	Director	London, X0
Richard Shea	Director	Cary, NC
Richard Shea	Executive Officer	Cary, NC
Benjamin Rovinski	Director	Mendham, NJ
Ken Williams	Director	Burlington, NC
Elizabeth Stoner	Director	Cambridge, MA
David Clemmons	Director	Chapel Hill, NC
David Clemmons	Executive Officer	Chapel Hill, NC
Bonnie Layman	Executive Officer	Chapel Hill, NC
Vaughn Kailian	Director	Chapel Hill, NC

Other filings by this issuer (5)

Filed	Form	Offering	Sold
2016-01-06	D	$3.0M	$3.0M
2015-01-21	D/A	$19.1M	$13.1M
2013-11-19	D/A	$16.0M	$9.0M
2013-08-23	D	$1.5M	$1.0M
2012-09-24	D	$16.0M	$6.0M

More